The Supreme Court’s unanimous decision to overturn patents on human genes is a victory for genetic counselors, patients and advocacy groups alike. Ellen Matloff, Director of the Yale Cancer Genetic Counseling Program and plaintiff on this historical case, shares her perspective on the harmful effects such patents can have and how this ruling has opened the gateway toward increased opportunities for genetic testing.
Click here to read the original article posted by Breast Cancer Action